Near-Infrared Fluorescence Imaging System Market Share

North American Market Forecast   

North America industry is expected to dominate majority revenue share of 39% by 2037. The growth of the market can be attributed majorly to the rapid adoption of technically advanced medical devices, increasing number of cancer cases, rise in the count of surgical procedures, and increasing disposable income in the region. It is observed that, approximately 41 to 52 million surgical procedures are performed each year in the United States.

APAC Market Statistics

The Asia Pacific near-infrared fluorescence imaging system market, amongst the market in all the other regions, is projected to hold the notable market share by the end of 2037. The growth of the market is credited to rising cases of cancer in the region and higher investment in medical devices. In 2022, there were around 5 million cancer cases in China, and nearly 3 million people died due to it. Moreover, lung cancer is the leading cause of death cancer death in the country. Furthermore, the "Promotion of Medical Device Parks" program from FY21 to FY25 was approved by the Department of Pharmaceuticals in August 2022 with a total financial investment of around USD 50 million, with a maximum support under the program of nearly USD 12 million for each Medical Device Park.